Difficult Summer Ahead for Stocks: Strategist

Eric Marshall, of Hodges Capital Management, shares his favorite small cap plays.

Novartis is opening on Tuesday the country's first plant to produce flu vaccines using cell cultures. These vaccines are faster, better and cheaper to make than egg-based methods, reports CNBC's Mike Huckman.

Joseph Balestrino, of Federated Investors, and CNBC's Steve Liesman discuss today's GDP data and the effect the economy is having on markets.

General Motors' Saab deal is off, reports CNBC's Phil LeBeau.